Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study

AIMS: Cardiac resynchronisation therapy (CRT) is effective treatment for selected patients with heart failure (HF) but has ~30% non-response rate. We evaluated whether specific biomarkers can predict outcome. METHODS: A prospective single-centre pilot study of consecutive unselected patients undergo...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Open Heart
Главные авторы: McAloon, Christopher J, Barwari, Temo, Hu, Jimiao, Hamborg, Thomas, Nevill, Alan, Hyndman, Samantha, Ansell, Valerie, Musa, Anntoniette, Jones, Julie, Goodby, Julie, Banerjee, Prithwish, O’Hare, Paul, Mayr, Manuel, Randeva, Harpal, Osman, Faizel
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Publishing Group 2018
Предметы:
Heart Failure and Cardiomyopathies
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6196945/
https://ncbi.nlm.nih.gov/pubmed/30364565
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/openhrt-2018-000899
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы